Replies to post #292420 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Ultimately I doubt Lilly’s drug will prove out in a P3 trial, but the valuation of an undisclosed stat sig P value for the primary endpoint and an unmet secondary outcome tells a story.